Tara C. Gangadhar, MD, summarizes the elements of care for patients receiving immune therapy, including selection criteria, response assessment monitoring and management of adverse events and toxicity, patient education and follow-up. Therapies discussed include nivolumab and ipilimumab.
Related Links
Published
December 23, 2015
Created by
BROADCASTMED